Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- 8-K Current report
- 3.1 Second Amended and Restated Certificate of Incorporation of Eqrx, Inc
- 3.2 Amended and Restated By-laws of Eqrx, Inc
- 10.1 Amended and Restated Registration Rights Agreement, Dated December [17], 2021, by and Among Eqrx, Inc. and the Stockholders Party Thereto
- 10.8 Eqrx, Inc. 2021 Stock Option and Incentive Plan
- 10.9 2021 Stock Option and Incentive Plan
- 10.10 Eqrx, Inc. 2021 Employee Stock Purchase Plan
- 16.1 Withum's Letter to the Securities and Exchange Commission, Dated December 20, 2021
- 99.1 Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets; Unregistered Sales of Equity Securities; Material Modifications to Rights of Security Holders; Changes in Registrant's Certifying Accountant; Changes in Control of Registrant; Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics; Change in Shell Company Status; Financial Statements and Exhibits
- Download Excel data file
- View Excel data file
EQRX similar filings
- 13 May 22 EQRx Reports First Quarter 2022 Financial Results and Recent Corporate Progress
- 23 Mar 22 EQRx Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Corporate Progress
- 10 Jan 22 Results of Operations and Financial Condition
- 20 Dec 21 Entry into a Material Definitive Agreement
- 17 Dec 21 Submission of Matters to a Vote of Security Holders
- 23 Nov 21 Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
- 29 Oct 21 Entry into a Material Definitive Agreement
Filing view
External links
Exhibit 16.1
December 20, 2021
Office of the Chief Accountant
Securities and Exchange Commission
100 F Street, NE
Washington, DC 20549
United States of America
Commissioners:
We have read the statements of EQRx, Inc. (formally known as CM Life Sciences III Inc.) included under Item 4.01 of its Form S-1 dated February 24, 2021. We agree with the statements concerning our Firm under Item 4.01, specifically in which we were informed of our dismissal on December 17, 2021.
We are not in a position to agree or disagree with other statements contained therein.
Very truly yours,
/s/ WithumSmith+Brown, PC
WithumSmith+Brown, PC
New York, New York